OS Therapies targets January BLA filing for OST-HER2 following successful Type C meeting with FDA
Proactive - Interviews for investors · Proactive Investors
December 15, 20257m 39s
Audio is streamed directly from the publisher (cdn.simplecast.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.